David H Quach

3PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 04, 2024
Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy.

Pei Y Teo, Youngrock Jung, David H Quach

|Dec 27, 2022
Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies.

David H Quach, Premal Lulla, Cliona M Rooney

|Jul 26, 2019
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.

David H Quach, Luis Becerra-Dominguez, Rayne H Rouce

Pageof 1